PDLI Financial Facts

Interest and other expense: -9.39M
Operating income: 158.91M
See Full Income Statement

Receivables from licensees: 250K
Cash and cash equivalents: 281.61M
See Full Balance Sheet

PDL BioPharma, Inc. (PDLI) Earnings

  |   Expand Research on PDLI
Next EPS Date 8/18/15 *Est. EPS Growth Rate +13.6% *Last Qtr.
Average EPS % Beat Rate -6.4% Revenue Growth Rate +7.2% *Last Qtr.
Average % Move 1-Wk after EPS -0.1% Normal Earnings Time After Close
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
5/6/15 Q115 $0.50$0.52 -$0.02$149.7M$140.8M N/A Details
2/23/15 Q414 $0.32$0.57 -$0.25$117.1M$158.15M N/A Details
11/10/14 Q314 $0.61$0.56 +$0.05$164.6M$165.1M N/A Details
8/18/14 Q214 $0.52$0.46 +$0.06$162.8M$134.07M N/A Details
5/12/14 Q114 $0.44$0.45 -$0.01$139.7M$130.93M N/A Details
3/3/14 Q413 $0.39$0.43 -$0.04$110.1M$115.22M N/A Details
11/6/13 Q313 $0.36$0.37 -$0.01$97.3M$97.09M N/A Details
8/8/13 Q213 $0.62$0.54 +$0.08$143.6M$138.2M N/A Details